Serum cholesterol and the risk of developing hormonally driven cancers: A narrative review

por Murdock, Dana J., Sanchez, Robert J., Mohammadi, Kusha A., Fazio, Sergio, Geba, Gregory P.
Publicado 2022

Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials

por Mohammadi, Kusha A., Brackin, Taylor, Schwartz, Gregory G., Steg, Philippe Gabriel, Szarek, Michael, Manvelian, Garen, Pordy, Robert, Fazio, Sergio, Geba, Gregory P.
Publicado 2023

Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles

por Li, Dateng, Xu, Meng, Hooper, Andrea T., Rofail, Diana, Mohammadi, Kusha A., Chen, Yiziying, Ali, Shazia, Norton, Thomas, Weinreich, David M., Musser, Bret J., Hamilton, Jennifer D., Geba, Gregory P.
Publicado 2023